$EVH
Evolent Health, Inc. Stock $evh

$evh Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000162890818000015 Filed on March 01, 2018

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$113.7M	$107.9M	$107.1M
YoY Change	29.22%	79.23%	89.45%
Cost Of Revenue	$65.50M	$68.30M	$68.00M
YoY Change	9.35%	101.47%	107.32%
Gross Profit	$48.20M	$39.60M	$39.10M
YoY Change	71.53%	50.57%	64.98%
Gross Profit Margin	42.38%	36.7%	36.52%
Selling, General & Admin	$55.20M	$45.83M	$51.09M
YoY Change	-4.17%	19.37%	55.97%
% of Gross Profit	114.52%	115.74%	130.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.13M	$2.300M	$1.900M
YoY Change	71.49%	155.56%	137.5%
% of Gross Profit	23.09%	5.81%	4.86%
Operating Expenses	$132.0M	$121.9M	$126.2M
YoY Change	8.28%	60.33%	82.49%
Operating Profit	-$83.78M	-$14.02M	-$19.12M
YoY Change	-10.67%	-11.48%	51.37%
Interest Expense	-$300.0K	$880.0K	$947.0K
YoY Change	-40.0%
% of Operating Profit
Other Income/Expense, Net	$200.0K	$15.00K	$3.000K
YoY Change		1400.0%	200.0%
Pretax Income	-$18.40M	-$14.84M	-$20.40M
YoY Change	-46.36%	-7.41%	64.9%
Income Tax	-$4.600M	-$1.714M	-$700.0K
% Of Pretax Income
Net Earnings	-$13.16M	-$12.59M	-$16.91M
YoY Change	-24.4%	12.31%	101.56%
Net Earnings / Revenue	-11.57%	-11.67%	-15.79%
Basic Earnings Per Share	-$0.18	-$0.18	-$0.28
Diluted Earnings Per Share	-$0.18	-$0.18	-$0.28
COMMON SHARES
Basic Shares Outstanding		70.33M shares	59.48M shares
Diluted Shares Outstanding		70.33M shares	59.48M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$238.4M	$287.1M	$124.0M
YoY Change	33.26%	80.0%	-6.56%
Cash & Equivalents	$238.4M	$287.1M	$99.98M
Short-Term Investments	$0.00	$0.00	$24.00M
Other Short-Term Assets	$70.80M	$21.20M	$22.90M
YoY Change	55.95%	112.0%	205.33%
Inventory
Prepaid Expenses
Receivables	$48.95M	$43.97M	$45.80M
Other Receivables	$20.00M	$0.00	$0.00
Total Short-Term Assets	$378.2M	$352.3M	$192.6M
YoY Change	42.73%	84.05%	12.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$50.92M	$46.93M	$40.19M
YoY Change	63.32%	122.17%	117.64%
Goodwill	$628.2M	$628.3M	$628.7M
YoY Change	0.26%	36.68%	36.75%
Intangibles	$241.3M	$249.5M	$254.5M
YoY Change	-6.82%	53.26%	53.81%
Long-Term Investments	$1.500M	$700.0K	$1.100M
YoY Change	-31.82%	-72.0%	-95.96%
Other Assets	$9.328M	$9.364M	$9.483M
YoY Change	-7.12%	-22.73%	-3.81%
Total Long-Term Assets	$934.5M	$946.7M	$945.7M
YoY Change	-0.04%	43.47%	38.62%
TOTAL ASSETS
Total Short-Term Assets	$378.2M	$352.3M	$192.6M
Total Long-Term Assets	$934.5M	$946.7M	$945.7M
Total Assets	$1.313B	$1.299B	$1.138B
YoY Change	9.41%	52.6%	33.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$42.93M	$27.29M	$26.28M
YoY Change	-2.19%	88.4%	112.36%
Accrued Expenses	$29.57M	$21.09M	$25.92M
YoY Change	1.41%	78.17%	204.46%
Deferred Revenue	$24.81M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$132.7M	$105.5M	$101.8M
YoY Change	0.57%	61.44%	79.39%
LONG-TERM LIABILITIES
Long-Term Debt	$121.4M	$121.2M	$120.9M
YoY Change	0.91%
Other Long-Term Liabilities	$9.861M	$9.982M	$10.02M
YoY Change	-32.71%	24.82%	25.74%
Total Long-Term Liabilities	$9.861M	$9.982M	$10.02M
YoY Change	-32.71%	24.82%	25.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$132.7M	$105.5M	$101.8M
Total Long-Term Liabilities	$9.861M	$9.982M	$10.02M
Total Liabilities	$266.4M	$243.3M	$243.9M
YoY Change	-7.41%	166.07%	188.11%
SHAREHOLDERS EQUITY
Retained Earnings	$85.95M	$99.11M	$111.7M
YoY Change	-41.38%	-39.58%	-36.26%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.011B	$1.020B	$859.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.313B	$1.299B	$1.138B
YoY Change	9.41%	52.6%	33.48%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	-$13.16M	-$12.59M	-$16.91M
YoY Change	-24.4%	12.31%	101.56%
Depreciation, Depletion And Amortization	$11.13M	$2.300M	$1.900M
YoY Change	71.49%	155.56%	137.5%
Cash From Operating Activities	$6.030M	$3.820M	-$3.040M
YoY Change	-128.05%	-51.71%	171.43%
INVESTING ACTIVITIES
Capital Expenditures	-$6.500M	-$8.920M	-$6.450M
YoY Change	47.39%	131.09%	64.96%
Acquisitions
YoY Change
Other Investing Activities	-$21.74M	$23.55M	$3.170M
YoY Change	-68.68%	-4810.0%	-448.35%
Cash From Investing Activities	-$28.24M	$14.63M	-$3.280M
YoY Change	-61.76%	-436.32%	-31.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.64M	163.5M	-10.98M
YoY Change	-85.51%	15041.67%	4673.91%
NET CHANGE
Cash From Operating Activities	6.030M	3.820M	-3.040M
Cash From Investing Activities	-28.24M	14.63M	-3.280M
Cash From Financing Activities	21.64M	163.5M	-10.98M
Net Change In Cash	-570.0K	182.0M	-17.30M
YoY Change	-101.06%	3821.98%	180.84%
FREE CASH FLOW
Cash From Operating Activities	$6.030M	$3.820M	-$3.040M
Capital Expenditures	-$6.500M	-$8.920M	-$6.450M
Free Cash Flow	$12.53M	$12.74M	$3.410M
YoY Change	-173.32%	8.24%	22.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001628908
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	1191700000	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	Evolent Health, Inc.
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016	evh	Abandonment Amortization AbandonmentAmortization	360000	USD
CY2017	evh	Abandonment Amortization AbandonmentAmortization	1239000	USD
CY2016	evh	Adjustmentsto Additional Paidin Capital Adjustmentfrom Adoptionof New Accounting Principle AdjustmentstoAdditionalPaidinCapitalAdjustmentfromAdoptionofNewAccountingPrinciple	0	USD
CY2015	evh	Adjustmentsto Additional Paidin Capital Income Tax Benefitfrom Offering Reorganization AdjustmentstoAdditionalPaidinCapitalIncomeTaxBenefitfromOfferingReorganization	2144000	USD
CY2015	evh	Adjustmentsto Additional Paidin Capital Noncash Issuanceof Common Stock AdjustmentstoAdditionalPaidinCapitalNoncashIssuanceofCommonStock	21810000	USD
CY2015	evh	Adjustmentto Additional Paidin Capital Effectsof Merger AdjustmenttoAdditionalPaidinCapitalEffectsofMerger	34875000	USD
CY2016	evh	Adjustmentto Additional Paidin Capital Effectsof Merger AdjustmenttoAdditionalPaidinCapitalEffectsofMerger	0	USD
CY2017	evh	Adjustmentto Additional Paidin Capital Effectsof Merger AdjustmenttoAdditionalPaidinCapitalEffectsofMerger	0	USD
CY2015	evh	Adjustmentto Additional Paidin Capital Reclassificationof Deferred Offering Costs Acquired AdjustmenttoAdditionalPaidinCapitalReclassificationofDeferredOfferingCostsAcquired	3154000	USD
CY2016	evh	Adjustmentto Additional Paidin Capital Reclassificationof Deferred Offering Costs Acquired AdjustmenttoAdditionalPaidinCapitalReclassificationofDeferredOfferingCostsAcquired	0	USD
CY2017	evh	Adjustmentto Additional Paidin Capital Reclassificationof Deferred Offering Costs Acquired AdjustmenttoAdditionalPaidinCapitalReclassificationofDeferredOfferingCostsAcquired	0	USD
CY2015	evh	Business Acquisition Pro Forma Adjustments Removalof Transaction Costs BusinessAcquisitionProFormaAdjustmentsRemovalofTransactionCosts	1200000	USD
CY2015	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-28684000	USD
CY2017	evh	Paymentsto Acquire Productive Assetsand Businesses PaymentstoAcquireProductiveAssetsandBusinesses	3694000	USD
CY2016	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-57433000	USD
CY2015	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-93906000	USD
CY2016	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-225091000	USD
CY2015Q2	evh	Business Combination Fair Value Adjustment Deferred Revenue BusinessCombinationFairValueAdjustmentDeferredRevenue	4900000	USD
CY2017Q4	evh	Cash Fdic Insured Amount Percentage CashFDICInsuredAmountPercentage	0.74
CY2017Q4	evh	Cash Held In Money Market Funds Percentage CashHeldInMoneyMarketFundsPercentage	0.26
CY2015Q2	evh	Common Stock Numberof Classes CommonStockNumberofClasses	2	class
CY2015	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	57398000	USD
CY2016	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	155177000	USD
CY2017	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	269352000	USD
CY2016Q4	evh	Deferred Tax Assets Internally Developed Software Costs DeferredTaxAssetsInternallyDevelopedSoftwareCosts	7137000	USD
CY2017Q4	evh	Deferred Tax Assets Internally Developed Software Costs DeferredTaxAssetsInternallyDevelopedSoftwareCosts	3974000	USD
CY2016Q4	evh	Deferred Tax Assets Startupand Organizational Costs DeferredTaxAssetsStartupandOrganizationalCosts	321000	USD
CY2017Q4	evh	Deferred Tax Assets Startupand Organizational Costs DeferredTaxAssetsStartupandOrganizationalCosts	185000	USD
CY2015	evh	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceTaxCutsAndJobsActOf2017Percent	0.000
CY2016	evh	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceTaxCutsAndJobsActOf2017Percent	0.000
CY2017	evh	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceTaxCutsAndJobsActOf2017Percent	0.437
CY2015	evh	Effective Income Tax Rate Reconciliation Nondeductible Expense Goodwill Associatedwith Reorganization Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseGoodwillAssociatedwithReorganizationPercent	-0.401
CY2016	evh	Effective Income Tax Rate Reconciliation Nondeductible Expense Goodwill Associatedwith Reorganization Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseGoodwillAssociatedwithReorganizationPercent	0.000
CY2017	evh	Effective Income Tax Rate Reconciliation Nondeductible Expense Goodwill Associatedwith Reorganization Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseGoodwillAssociatedwithReorganizationPercent	0.000
CY2015	evh	Effective Income Tax Rate Reconciliation Stock Based Compensation Excess Tax Benefits Percent EffectiveIncomeTaxRateReconciliationStockBasedCompensationExcessTaxBenefitsPercent	0.000
CY2016	evh	Effective Income Tax Rate Reconciliation Stock Based Compensation Excess Tax Benefits Percent EffectiveIncomeTaxRateReconciliationStockBasedCompensationExcessTaxBenefitsPercent	0.001
CY2017	evh	Effective Income Tax Rate Reconciliation Stock Based Compensation Excess Tax Benefits Percent EffectiveIncomeTaxRateReconciliationStockBasedCompensationExcessTaxBenefitsPercent	0.031
CY2017Q4	evh	Goodwill Impairment Testing Percentage Share Price Decrease GoodwillImpairmentTestingPercentageSharePriceDecrease	0.424
CY2015	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Common Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofCommonStock	10083000	shares
CY2016	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Common Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofCommonStock	0	shares
CY2017	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Common Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofCommonStock	0	shares
CY2015	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Convertible Preferred Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofConvertiblePreferredStock	9397000	shares
CY2016	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Convertible Preferred Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofConvertiblePreferredStock	0	shares
CY2017	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Convertible Preferred Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofConvertiblePreferredStock	0	shares
CY2017Q2	evh	Liabilities Subject To Compromise Impact Of Lease Termination LiabilitiesSubjectToCompromiseImpactOfLeaseTermination	500000	USD
CY2017	evh	Liabilities Subject To Compromise Impact Of Lease Termination LiabilitiesSubjectToCompromiseImpactOfLeaseTermination	496000	USD
CY2015	evh	Net Income Loss Attributableto Noncontrolling Interest Includedin Computationof Diluted Earnings Per Share When Net Income Exists During Period NetIncomeLossAttributabletoNoncontrollingInterestIncludedinComputationofDilutedEarningsPerShareWhenNetIncomeExistsDuringPeriod	-12680000	USD
CY2016	evh	Net Income Loss Attributableto Noncontrolling Interest Includedin Computationof Diluted Earnings Per Share When Net Income Exists During Period NetIncomeLossAttributabletoNoncontrollingInterestIncludedinComputationofDilutedEarningsPerShareWhenNetIncomeExistsDuringPeriod	0	USD
CY2017	evh	Net Income Loss Attributableto Noncontrolling Interest Includedin Computationof Diluted Earnings Per Share When Net Income Exists During Period NetIncomeLossAttributabletoNoncontrollingInterestIncludedinComputationofDilutedEarningsPerShareWhenNetIncomeExistsDuringPeriod	0	USD
CY2015	evh	Net Income Portion Attributableto Parent Priorto Reorganization NetIncomePortionAttributabletoParentPriortoReorganization	-28165000	USD
CY2015	evh	Noncash Issuanceof Common Stock NoncashIssuanceofCommonStock	21810000	USD
CY2016	evh	Noncash Issuanceof Common Stock NoncashIssuanceofCommonStock	0	USD
CY2017	evh	Noncash Issuanceof Common Stock NoncashIssuanceofCommonStock	0	USD
CY2015	evh	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Measurement Period Adjustment NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationMeasurementPeriodAdjustment	0	USD
CY2016	evh	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Measurement Period Adjustment NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationMeasurementPeriodAdjustment	0	USD
CY2017	evh	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Measurement Period Adjustment NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationMeasurementPeriodAdjustment	1611000	USD
CY2015	evh	Noncontrolling Interest Decreasefrom Conversionof Shares NoncontrollingInterestDecreasefromConversionofShares	0	USD
CY2016	evh	Noncontrolling Interest Decreasefrom Conversionof Shares NoncontrollingInterestDecreasefromConversionofShares	28220000	USD
CY2017	evh	Noncontrolling Interest Decreasefrom Conversionof Shares NoncontrollingInterestDecreasefromConversionofShares	168883000	USD
CY2015Q2	evh	Numberof Classesof Common Stock NumberofClassesofCommonStock	2	class
CY2016Q4	evh	Numberof Customers Provided Risk Adjustment Services NumberofCustomersProvidedRiskAdjustmentServices	1	customer
CY2015	evh	Paymentsto Acquire Productive Assetsand Businesses PaymentstoAcquireProductiveAssetsandBusinesses	0	USD
CY2016	evh	Paymentsto Acquire Productive Assetsand Businesses PaymentstoAcquireProductiveAssetsandBusinesses	82560000	USD
CY2016Q4	evh	Prepaid Expenseand Other Assets Current Related Party PrepaidExpenseandOtherAssetsCurrentRelatedParty	4507000	USD
CY2017Q4	evh	Prepaid Expenseand Other Assets Current Related Party PrepaidExpenseandOtherAssetsCurrentRelatedParty	25000	USD
CY2015	evh	Stock Issued Decrease In Deferred Tax Liability StockIssuedDecreaseInDeferredTaxLiability	0	USD
CY2016	evh	Stock Issued Decrease In Deferred Tax Liability StockIssuedDecreaseInDeferredTaxLiability	1606000	USD
CY2017	evh	Stock Issued Decrease In Deferred Tax Liability StockIssuedDecreaseInDeferredTaxLiability	12857000	USD
CY2017	evh	Stock Issued During Period New Issues Tax Impact StockIssuedDuringPeriodNewIssuesTaxImpact	12857000	USD
CY2016	evh	Stock Issued During Period Shares Conversionof Convertible Securities Tax Impact StockIssuedDuringPeriodSharesConversionofConvertibleSecuritiesTaxImpact	1606000	USD
CY2016	evh	Stock Issued During Period Value Acceleration Of Equity Awards As Part Of Business Combination StockIssuedDuringPeriodValueAccelerationOfEquityAwardsAsPartOfBusinessCombination	3899000	USD
CY2016	evh	Stock Issued During Period Value Acquisitions Tax Effect StockIssuedDuringPeriodValueAcquisitionsTaxEffect	1427000	USD
CY2015	evh	Tax Benefit Related To Intangible Assets TaxBenefitRelatedToIntangibleAssets	0	USD
CY2016	evh	Tax Benefit Related To Intangible Assets TaxBenefitRelatedToIntangibleAssets	0	USD
CY2017	evh	Tax Benefit Related To Intangible Assets TaxBenefitRelatedToIntangibleAssets	2042000	USD
CY2017Q4	evh	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpense	27500000	USD
CY2017Q4	evh	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit	2800000	USD
CY2017Q4	evh	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Alternative Minimum Tax Provisional Income Tax Benefit TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAlternativeMinimumTaxProvisionalIncomeTaxBenefit	300000	USD
CY2017Q4	evh	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Valuation Allowance Deferred Tax Asset Decrease Amount TaxCutsAndJobsActOf2017IncompleteAccountingValuationAllowanceDeferredTaxAssetDecreaseAmount	30200000	USD
CY2017	evh	Tax Receivable Agreement Percentof Cash Savings Not Paidto Shareholders TaxReceivableAgreementPercentofCashSavingsNotPaidtoShareholders	0.15
CY2017	evh	Tax Receivable Agreement Percentof Cash Savings Paidto Shareholders TaxReceivableAgreementPercentofCashSavingsPaidtoShareholders	0.85
CY2017Q4	evh	Tax Receivables Agreement Percentof Tax Savingstobe Paid TaxReceivablesAgreementPercentofTaxSavingstobePaid	0.85
CY2017Q4	evh	Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate	800000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	43892000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	42930000	USD
CY2016Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	13480000	USD
CY2017Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	10284000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40635000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48947000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29160000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29572000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5236000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14458000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	555250000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	924153000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14730000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16147000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20437000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14730000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22501000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20437000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	914000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5800000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12500000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22800000	USD
CY2016Q4	us-gaap	Assets Assets	1199839000	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19469000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15840000	shares
CY2017Q4	us-gaap	Assets Assets	1312697000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	264966000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	378182000	USD
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-1.50
CY2016	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-3.30
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-1.50
CY2016	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-3.30
CY2015	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-65222000	USD
CY2016	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-167658000	USD
CY2015	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	311639000	USD
CY2016	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	361944000	USD
CY2015	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2086000	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	400000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	446000	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	229000	USD
CY2015	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	100000	USD
CY2016	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1400000	USD
CY2017	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4900000	USD
CY2015	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	13065000	USD
CY2016	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2017	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134563000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	238433000	USD
CY2014Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	152011000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170029000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295363000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295400000	USD
CY2015	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	152011000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	18018000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	125334000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	39014000	USD
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2017	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2015	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	2184000	USD
CY2016	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	0	USD
CY2017	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	0	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	368000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2017	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	196000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	634000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	266000	USD
CY2015	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	7092000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9708000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3202000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8258000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-10846000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	100000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	62513000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4523000	USD
CY2015	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	23460000	USD
CY2016	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-10755000	USD
CY2017	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-7271000	USD
CY2015	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	15202000	USD
CY2016	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	91000	USD
CY2017	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-7371000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	20481000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	24807000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1166000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1138000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3102000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	68043000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	55287000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	41667000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2086000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	60076000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	51197000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	509000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-69000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26376000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	53201000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	20846000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2437000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	62513000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	4523000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	20846000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2437000	USD
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2400000	USD
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	4300000	USD
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	8000000	USD
CY2015	us-gaap	Depreciation Depreciation	1200000	USD
CY2016	us-gaap	Depreciation Depreciation	2600000	USD
CY2017	us-gaap	Depreciation Depreciation	9200000	USD
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7166000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17224000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32368000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7166000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17224000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32368000	USD
CY2016Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	8258000	USD
CY2017Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	3358000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.91
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.55
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2016Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	3211000	USD
CY2017Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	719000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.14
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.93
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.91
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.55
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.068
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.068
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.045
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.087
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.044
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.001
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.340
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.360
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	-0.050
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.000
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.014
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.110
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.046
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.187
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.000
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.010
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.000
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.018
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.049
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.040
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.033
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	38408000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	35390000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	100000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2017	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	24619000	USD
CY2015	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2016	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2017	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2086000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-400000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	10386000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8300000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8700000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18400000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	41238000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	150583000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	23209000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10931000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	14666000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	18801000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	23071000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	277323000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	282499000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	258923000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	241261000	USD
CY2015	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
CY2016	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-6456000	USD
CY2017	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
CY2015	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	414133000	USD
CY2016	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	0	USD
CY2017	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	0	USD
CY2015Q4	us-gaap	Goodwill Goodwill	608903000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	626569000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	628186000	USD
CY2015Q2	us-gaap	Goodwill Goodwill	608900000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	178266000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	0	USD
CY2016Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
CY2017	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	1617000	USD
CY2016Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	44341000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	197000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	35000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	44503000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	44341000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	44503000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	343289000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-237533000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-76404000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-28165000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-841000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1755000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23500000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23475000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10755000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6637000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	674000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2764000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6371000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5563000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11756000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11044000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11258000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3788000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	15229000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2781000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-17998000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1200000	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3548000	USD
CY2015	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	11402000	USD
CY2016	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	6678000	USD
CY2017	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3303000	USD
CY2015	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	58000	USD
CY2016	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-153000	USD
CY2017	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1782000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2036000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9968000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2729000	USD
CY2016	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	4950000	USD
CY2017	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	3805000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	258923000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	241261000	USD
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	169000000	USD
CY2017	us-gaap	License And Services Revenue LicenseAndServicesRevenue	405484000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	120283000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1312697000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	131941000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	132699000	USD
CY2015	us-gaap	License And Services Revenue LicenseAndServicesRevenue	76972000	USD
CY2016	us-gaap	License And Services Revenue LicenseAndServicesRevenue	215868000	USD
CY2015Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	0	USD
CY2016Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	6100000	USD
CY2017Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	0	USD
CY2016	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	6460000	USD
CY2017	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	0	USD
CY2015	us-gaap	Interest Expense InterestExpense	0	USD
CY2016	us-gaap	Interest Expense InterestExpense	247000	USD
CY2017	us-gaap	Interest Expense InterestExpense	3636000	USD
CY2015	us-gaap	Interest Paid InterestPaid	0	USD
CY2016	us-gaap	Interest Paid InterestPaid	0	USD
CY2017	us-gaap	Interest Paid InterestPaid	2472000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	293000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	970000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	1656000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	2159000	USD
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	1531000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	287725000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	266391000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1199839000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	121394000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	209588000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	35427000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	214163000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	150185000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	165557000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43684000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-96657000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12265000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18468000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35510000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-27958000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	332494000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-122740000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-8387000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-11208000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-17407000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-159742000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-18012000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-16905000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-12588000	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-631000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9102000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-159742000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	330310000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-159742000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-13160000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2793000	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-541000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-60665000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12680000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-51071000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3612000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4567000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7786000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-67036000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5137000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-60665000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	319814000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-60665000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	1148000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	USD
CY2017	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	USD
CY2016Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	USD
CY2017Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	20000000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	139850000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	224527000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	69147000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	76049000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	121884000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	491607000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	127693000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	126188000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	121932000	USD
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	131977000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	507790000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-42972000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-237419000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-72840000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	41292000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	8328000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2530000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2870000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7001000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7101000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	13462000	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2300000	USD
CY2016	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	4000	USD
CY2017	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	171000	USD
CY2015Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3200000	USD
CY2015	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1361000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5900000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	10900000	USD
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	207600000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14655000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9861000	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-172000	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-916000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-490000	USD
CY2015	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	365000	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1272000	USD
CY2015	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	0	USD
CY2016	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	3000000	USD
CY2017	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	1128000	USD
CY2015	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	54234000	USD
CY2016	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2017	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2015	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	USD
CY2016	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	USD
CY2017	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	20000000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6515000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15526000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27848000	USD
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2184000	USD
CY2016	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2017	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11011000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8404000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	10043000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	9328000	USD
CY2015	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2016	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	121250000	USD
CY2017	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2015Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	209100000	USD
CY2015	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	209087000	USD
CY2016	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2017	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	166947000	USD
CY2015	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	6285000	USD
CY2016	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	28041000	USD
CY2017	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-4200000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	152000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1259000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4082000	USD
CY2015	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	4000000	USD
CY2016	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	9379000	USD
CY2017	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	44210000	USD
	us-gaap	Profit Loss ProfitLoss	347979000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	319814000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-173811000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	-11999000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-15775000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	-25193000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-226778000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-23149000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	-19698000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	-13129000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	-13791000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-69767000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36415000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	65380000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31179000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50922000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	USD
CY2017Q4	us-gaap	Purchase Obligation PurchaseObligation	6997000	USD
CY2017Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	USD
CY2017Q4	us-gaap	Purchase Obligation Due In Fourth And Fifth Year PurchaseObligationDueInFourthAndFifthYear	0	USD
CY2017Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	6567000	USD
CY2017Q4	us-gaap	Purchase Obligation Due In Second And Third Year PurchaseObligationDueInSecondAndThirdYear	430000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5800000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11100000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17200000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	34416000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	54248000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1050000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2682000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	40416000	USD
CY2017Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	65685000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	34416000	USD
CY2017Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	62398000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	6000000	USD
CY2017Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	3287000	USD
CY2016Q4	us-gaap	Restricted Investments RestrictedInvestments	-4950000	USD
CY2017Q4	us-gaap	Restricted Investments RestrictedInvestments	-8755000	USD
CY2016Q4	us-gaap	Restricted Investments Current RestrictedInvestmentsCurrent	0	USD
CY2017Q4	us-gaap	Restricted Investments Current RestrictedInvestmentsCurrent	8150000	USD
CY2016Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	4950000	USD
CY2017Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	605000	USD
CY2015	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	USD
CY2016	us-gaap	Restricted Stock Expense RestrictedStockExpense	3897000	USD
CY2017	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	USD
CY2016	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	254188000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	75286000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	160692000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	146617000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	85952000	USD
CY2015	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	96878000	USD
CY2016Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	49449000	USD
CY2016Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	56518000	USD
CY2017Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	107912000	USD
CY2017Q4	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	113729000	USD
CY2016Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	60210000	USD
CY2016Q4	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	88011000	USD
CY2017Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	106238000	USD
CY2017	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	434950000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.428
CY2017Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	107071000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.450
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.450
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	205670000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	14730000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	18604000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	20437000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.018
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.015
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.021
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.014
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.013
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.019
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.78
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	500000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3800000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	14200000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	227000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	961000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.41
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.69
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.38
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	50193000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23325000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6005000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5951000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.44
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.38
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3156000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	23379000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5414000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	8.43
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.18
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.62
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	18.64
CY2015Q3	us-gaap	Share Price SharePrice	19.51
CY2015Q4	us-gaap	Share Price SharePrice	14.73
CY2016Q1	us-gaap	Share Price SharePrice	10.33
CY2017Q4	us-gaap	Share Price SharePrice	12.01
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	22678000	USD
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y10M18D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M10D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y1M11D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	11100000	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	12400000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	13000000	USD
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	44341000	USD
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	788000	shares
CY2015	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2016	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	177782000	USD
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	39273000	USD
CY2016	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	332793000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	166947000	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2193000	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-1272000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	152000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1259000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4082000	USD
CY2017	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-908000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	702526000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	1010879000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2070000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	934579000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	912114000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1046306000	USD
CY2015	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2016	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	1036000	USD
CY2017	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2015	us-gaap	Technology Services Revenue TechnologyServicesRevenue	19906000	USD
CY2016	us-gaap	Technology Services Revenue TechnologyServicesRevenue	38320000	USD
CY2017	us-gaap	Technology Services Revenue TechnologyServicesRevenue	29466000	USD
CY2016Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	1800000	USD
CY2017Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	2400000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	762000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	420000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	74000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1108000	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46136000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45031000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64351000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25129000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45031000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64351000	shares
CY2017	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue consists of billings or payments received in advance of providing the requisite services or other instances where the revenue recognition criteria have not been met. Amounts deferred that are not anticipated to be recognized as revenue within a year of the balance sheet date are reported as long-term deferred liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Estimates and Assumptions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates. In the accompanying consolidated financial statements, estimates are used for, but not limited to, the valuation of assets, liabilities, consideration related to business combinations and asset acquisitions, revenue recognition including discounts and credits, estimated selling prices for deliverables in multiple element arrangements, contingent payments, allowance for doubtful accounts, depreciable lives of assets, impairment of long lived assets (including equity method investments), stock-based compensation, deferred income taxes and valuation allowance, contingent liabilities, valuation of intangible assets (including goodwill), purchase price allocation in taxable stock transactions and the useful lives of intangible assets.</font></div></div>

Files In Submission

Name	View Source	Status
0001628908-18-000015-index-headers.html	Edgar Link	pending
0001628908-18-000015-index.html	Edgar Link	pending
0001628908-18-000015.txt	Edgar Link	pending
0001628908-18-000015-xbrl.zip	Edgar Link	pending
a123117exhibit211.htm	Edgar Link	pending
a123117exhibit231pwcconsent.htm	Edgar Link	pending
a123117exhibit311.htm	Edgar Link	pending
a123117exhibit312.htm	Edgar Link	pending
a123117exhibit321.htm	Edgar Link	pending
a123117exhibit322.htm	Edgar Link	pending
evh-20171231.xml	Edgar Link	completed
evh-20171231.xsd	Edgar Link	pending
evh-20171231_cal.xml	Edgar Link	unprocessable
evh-20171231_def.xml	Edgar Link	unprocessable
evh-20171231_lab.xml	Edgar Link	unprocessable
evh-20171231_pre.xml	Edgar Link	unprocessable
evh123115_chart-23299a07.jpg	Edgar Link	pending
evh12311710-k.htm	Edgar Link	pending
evh2017orgchartv228.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVH
Evolent Health, Inc. Stock $evh

2017 Q4 Form 10-K Financial Statement

#000162890818000015 Filed on March 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVH Evolent Health, Inc. Stock $evh

2017 Q4 Form 10-K Financial Statement

#000162890818000015 Filed on March 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVH
Evolent Health, Inc. Stock $evh